Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does HIV disease progression influence epidermal Langerhans cell density?

R Nandwani1, B G Gazzard, S E Barton

  • 1Department of HIV/Genitourinary Medicine, Chelsea & Westminster Hospital, London, U.K.

The British Journal of Dermatology
|June 1, 1996
PubMed
Summary

This study found no link between the number of Langerhans cells (LC) in the skin and the stage of human immunodeficiency virus (HIV) disease. Epidermal LC density remains stable regardless of HIV progression, suggesting other factors influence skin issues in HIV.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modelling the effect of race surface and racehorse limb parameters on in silico fetlock motion and propensity for injury.

Equine veterinary journal·2017
Same author

Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign.

HIV medicine·2016
Same author

2015 European guidelines for the management of partners of persons with sexually transmitted infections.

Journal of the European Academy of Dermatology and Venereology : JEADV·2015
Same author

A compartmental pharmacokinetic evaluation of long-acting rilpivirine in HIV-negative volunteers for pre-exposure prophylaxis.

Clinical pharmacology and therapeutics·2014
Same author

Missed opportunities for HIV diagnosis: a three-year audit in the West of Scotland.

Scottish medical journal·2013
Same author

Pancreatic insufficiency in patients with HIV infection: role of didanosine questioned.

HIV medicine·2012

Area of Science:

  • Immunology
  • Dermatology
  • Virology

Background:

  • Langerhans cells (LC) are crucial antigen-presenting cells in the skin.
  • Human immunodeficiency virus (HIV) can infect LC, potentially impacting skin health.
  • Previous research on epidermal LC density in HIV-infected individuals yielded inconsistent findings.

Purpose of the Study:

  • To investigate the association between epidermal Langerhans cell density and the clinical stage of human immunodeficiency virus (HIV) disease.
  • To clarify the role of LC in the context of HIV infection and its manifestations.

Main Methods:

  • A prospective, case-control study involving 56 HIV-positive men and 15 HIV-negative controls.
  • Skin cryosections were analyzed using CD1 monoclonal antibody staining and immunoperoxidase methods.

Related Experiment Videos

  • Epidermal LC density was quantified using three distinct methods: per basement membrane length, per epidermal area, and per epidermal surface length.

    • Main Results:

    • No statistically significant association was found between epidermal LC density and the stage of HIV clinical disease across all quantification methods.
    • Contrary to some prior smaller studies, this research did not detect a correlation between LC numbers and disease progression.
    • The findings suggest a potential preservation of static LC numbers in the skin despite HIV infection.

    Conclusions:

    • Epidermal Langerhans cell density does not appear to be a reliable indicator of HIV clinical disease stage.
    • Further research into the kinetics and function of Langerhans cells is necessary to understand their role in HIV pathogenesis.
    • Hypotheses are proposed to explain the observed preservation of LC numbers in the skin during HIV infection.